Members of the picornavirus family of small, nonenveloped, positive-stranded RNA viruses, which includes enterovirus 71, poliovirus, hepatitis A virus, the coxsackieviruses, and the rhinoviruses, are a frequent cause of infection worldwide. Despite the fact that members of this family infect more humans than any other group of viruses (Rotbart, 2002) , host factors that control picornaviral replication are poorly understood. Even less is known about host factors that control picornaviral neurovirulence and clearance of picornaviruses from the central nervous system (CNS) . We and others have used the Theiler's murine encephalomyelitis virus (TMEV) as a mouse model of picornavirus infection of the CNS Jin et al, 2007; Rubio et al, 2006; Tsunoda et al, 2006) . Previous studies have extensively characterized the role of antiviral CD8+ cytotoxic T lymphocytes (CTLs) in the clearance of TMEV from the brain during acute infection (Mendez-Fernandez et al, 2003) , and it is clear in mice of the H-2 b major histocompatibility complex (MHC) class I haplotype that CTLs specific for the VP2 121−130 TMEV peptide are responsible for viral clearance during the first 2 weeks of CNS infection (Myoung et al, 2007) . However, the role of additional host factors such as costimulatory molecules has not been thoroughly explored.
NKG2D is a natural cytotoxicity receptor expressed on natural killer cells (NKCs) and on activated CTLs in mice (Eagle and Trowsdale, 2007) . This receptor recognizes stress-and infection-regulated MHC class I-like molecules such as Rae1, Mult1, and H60 expressed on the surface of murine cells (Raulet, 2003) . Although NKG2D is a direct mediator of cytotoxicity for NKCs, it serves as a costimulatory receptor for CTLs and augments cytotoxicity downstream from T-cell receptor recognition of peptides presented on MHC class I (Markiewicz et al, 2005) . Because the mechanisms that direct CTL-mediated clearance of infected neural cells are unclear, we asked whether NKG2D-positive immune effectors are present in the CNS during acute TMEV infection, whether NKG2D ligands are expressed in the brain following infection, Using flow-cytometric analysis of a previously characterized preparation of brain-infiltrating leukocytes (BILs) (Howe et al, 2007) , we measured the number of NKG2D-positive immune cells present in + cells increased between 3 (A) and 7 (D) dpi. Likewise, the number of CD45 hi cells positive for both CD8 and NKG2D increased from 20% at 3 dpi (B) to 76% at 7 dpi (E). Moreover, the intensity of NKG2D surface labeling increased from a mean fluorescence intensity (MFI) of 35 at 3 dpi (shaded histogram in C) to 89 at 7 dpi (shaded histogram in F). The MFI for the isotype control was 4 at 3 dpi (open histogram in C) and 5 at 7 dpi (open histogram in F). BILs were further analyzed for antiviral specificity by costaining with an MHC class I tetramer loaded with the VP2 121−130 H-2D b -specific viral peptide (G-I). Of the cells that were both CD8 + and tetramer-positive (box "H" in G), 81% were also NKG2D-positive, with an MFI of 136 (H). In contrast, only 12% of cells that were CD8
+ but tetramer-negative (box "I" in G) were also NKG2D-positive, with an MFI of only 18 (I). hi BILs were CD8-positive, of which 20% ± 0.6% were also NKG2D augments picornavirus clearance C Deb and CL Howe 263 positive for the NKG2D costimulatory receptor. By 7 d.p.i., the BILs were comprised of 24% ± 2% CTLs, with 76% ± 2% of these cells positive for NKG2D (n = 4-6 mice per time point; mean ± 95% CI). Thus, between 3 and 7 d.p.i., the phenotype of immune cells infiltrating the CNS shifted toward a population that was enriched in NKG2D + CD8 + CD45 hi CTLs ( Figure 1A to F) . The presence of NKG2D-positive CTLs within the infected hippocampus (Wada and Fujinami, 1993) was confirmed by simultaneously immunostaining cryosections from mice at 7 d.p.i. with anti-CD8 (53-6.7; 1:100) and anti-NKG2D (CX5; 1:50) (Figure 2A to E) (Howe et al, 2004) .
In order to determine the viral specificity of the NKG2D-positive CTLs at 7 d.p.i., we costained BILs with anti-CD8, anti-NKG2D, and the TMEV VP2 121-130 -specific tetramer (Beckman Coulter Immunomics, San Diego, CA; 1:100) (Howe et al, 2007) . Flow cytometry revealed that 74% ± 2% of CD45
hi CD8 + cells were VP2-specific ( Figure 1G ), whereas none of these cells were stained by an irrelevant D b /E7 tetramer (data not shown) (MendezFernandez et al, 2005) . Moreover, 81% ± 2% of the VP2-specific CTLs were also NKG2D-positive (Figure 1H) , whereas only 12% ± 2% of the VP2 tetramernegative CTLs were positive for NKG2D ( Figure 1I ) (n = 4 mice; mean ± 95% CI). We conclude that a robust population of NKG2D-positive VP2-specific CTLs are present within the brain at 7 days after infection with TMEV.
Others have reported the up-regulation of NKG2D ligands following infection in a variety of peripheral tissues (Eagle and Trowsdale, 2007) . However, the up-regulation of these ligands by picornavirus infection has not been previously explored. We found that Rae1, Mult1, and H60 were all up-regulated within the hippocampus during acute TMEV infection, as determined by reverse transcriptase polymerase chain reaction (RT-PCR) analysis of RNA isolated from the excised hippocampus (see Table 1 for conditions). Of the three ligands we analyzed, Rae1 showed the most robust up-regulation, with a peak induction of 10 ± 1-fold over the uninfected hippocampus at 7 d.p.i. (F (4, 9) = 4.845, P = .017 by one-way analysis of variance [ANOVA] ; q(9, 5)=5.841, P = .012 with the SNK pairwise comparison between 0 and 7 d.p.i.; mean ± 95% CI) ( Figure 3A ). H60 and Mult1 were also up-regulated 2 ± 0.1-fold and 2 ± 0.2-fold over uninfected, respectively, at 7 d.p.i. (n = 3 mice; mean ± 95% CI) ( Figure 3A) .
In order to identify the cellular locus of NKG2D ligand expression in the hippocampus, we attempted, unsuccessfully, to immunostain fresh frozen or paraffin-embedded sections of hippocampus after fixation with paraformaldehyde, methanol, or ethanol:acetone. We tested specific anti-Rae1 (clone C Deb and CL Howe Note. Excised hippocampus was processed for RNA purification using the Qiagen RNeasy Lipid-Tissue kit. cDNA was prepared using the Roche 1st Strand cDNA Synthesis kit and analyzed using the Roche Universal Probe Library taqman probes identified above and the Roche TaqMan Master kit. Samples were amplified for 45 cycles using 95
• C melt for 10 s, 55
• C anneal for 30 s, and 72
• C elongate for 5 s. Primers are given as 5 to 3 . 186107; 1:25; R&D Systems) and anti-H60 (clone 205326; 1:100; R&D Systems) antibodies as well as a pan-specific NKG2D ligand antibody (goat antiRae1; 1:100; Santa Cruz Biotechnology) and the panspecific NKG2D-Fc chimeric molecule (R&D Systems Figure 3 NKG2D ligands are upregulated in the hippocampus during acute infection with TMEV and interference with NKG2D recognition of these ligands increases viral load in the CNS. qRT-PCR analysis of brain mRNA revealed a 10-fold upregulation of Rae1 at 7 dpi (A) as compared to the uninfected brain. Likewise, H60 and Mult1 were also upregulated throughout the acute phase of infection (A). Western blot analysis of hippocampal protein lysates showed the translational upregulation of H60, with peak expression at 7 dpi (B). The 50 kDa band (arrow) upregulated in hippocampus was also present in YAC-1 cell lysates (B). Treatment with the CX5 anti-NKG2D function blocking antibody throughout the acute phase of infection resulted in a 10-fold increase in viral load within the brain at 7 dpi (C). Bar graph shows mean ± 95% confidence interval. Five mice were treated in each group and individual viral titers are shown as black circles in (C). All CX5-treated mice showed increased viral titer.
139-NK; 1:10). Likewise, we attempted to confirm the expression of the NKG2D ligands at the protein level within the hippocampus by Western blot analysis of hippocampal lysates. Of the numerous antibodies tested (same as immunostaining, above), only the anti-H60 antibody (clone 205326; 1:100; R&D Systems) successfully identified a prominent band that was present within the hippocampus only after infection and which was also present in lysate from the YAC1 NK cell target line ( Figure 3B ). The apparent molecular weight of this prominent band (ca. 50 kDa) matches that described by Hasan and colleagues (Hasan et al, 2005) . The relative difference in mobility between the putative H60 band in the hippocampal lysate and the YAC-1 cell lysate may reflect differential expression of one of the three recently identified isoforms of H60 that share high sequence homology but differ in molecular weight (Takada et al, 2008) . We conclude that NKG2D ligands such as H60 are upregulated at both the transcriptional and translational level within the hippocampus following acute TMEV infection, but we are unable to identify the cells that express these ligands with the currently available immunologic tools.
Finally, we asked whether interruption of NKG2D-mediated recognition of NKG2D ligands was sufficient to alter viral load within the hippocampus. We used the CX5 function blocking antibody following a therapeutic regime adapted from Lanier and colleagues (100 μg/mouse intraperitoneally [i.p.] on −1, +1, and +4 d.p.i.; kindly provided by Dr. Lanier, University of California San Fransisco) . Control mice received an equivalent dose of polyclonal rat immunoglobulin G (IgG) . Plaque assay (Pavelko et al, 1998) of freshly excised brain homogenates at 7 d.p.i. revealed that CX5 treatment led to 9 ± 2 times more infectious virus as compared to control IgG-treated mice (U(5, 5) = 15, P = .008, Mann-Whitney rank sum test; mean ± 95% CI) ( Figure 3C ). Based on these observations, we propose that VP2-specific CTLs expressing NKG2D recognize NKG2D ligands such as Rae1 and H60 expressed on infected cells within the brain and thereby engage an enhanced cytotoxic response (Markiewicz et al, 2005 ) that contributes to the clearance of picornaviruses from the CNS.
In addition to expression on activated CTLs, NKG2D is also a primary cytotoxicity receptor for NKCs and NKC activity is certainly modulated by viral infection. We chose to specifically focus on the role of NKG2D on antiviral CTLs because the number of NKCs present within the brain during the peak of viral clearance is low compared to CTLs (ca. 10% of CD45
hi cells are NK1.1-positive at 7 d.p.i.; data not shown). However, we certainly cannot rule out a role for NKC-mediated recognition of NKG2D ligands on infected neural cells as part of an early response required for viral clearance. Likewise, NKG2D is expressed by subpopulations of CD4 T cells (SaezBorderias et al, 2006) , γ δ T cells (Dandekar et al, 
